Healthcare & Medical Devices Global On demand · 24-48h

Global MR-Linac Market Strategic Research Report

Global MR-Linac Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global MR-Linac Market
$6972025
10.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: High-field MR-Linac, Low-field MR-Linac

By Application: Prostate cancer, Pancreatic cancer, Liver cancer, Lung cancer, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Elekta AB, ViewRay Systems, Inc., MagnetTx Oncology Solutions Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 82 pages
Market size 2025
$697
Million USD
Forecast CAGR
10.6%
2025-2032
Forecast 2032
$1411
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global MR-Linac market size is predicted to grow from US$ 697 million in 2025 to US$ 1,334 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.

Magnetic resonance-guided radiation therapy system is a high-end tumor treatment equipment that deeply integrates magnetic resonance imaging (MR/MRI) with external beam radiation therapy devices, typically medical electronic linear accelerators, in both hardware and software.It aims to continuously acquire MR images with high soft-tissue contrast resolution before, during and even throughout treatment, and achieve more accurate dose delivery to tumors while better protecting surrounding normal tissues through online plan adaptation, real-time tracking and gating.In 2025, the global sales volume of MR-Linac was approximately 95 units, with an average price of about 7.5 million US dollars per unit, and the industry average gross profit margin stood at around 30%.

MR-Linac systems are evolving from "high-end demonstration equipment" to "capability platforms built around precision adaptive treatment". The focus of market competition is no longer merely the integration of imaging and radiotherapy hardware, but clinical workflow, online adaptive efficiency, motion management, physician team training, and hospital-wide collaboration capabilities. The current landscape is characterized by "dominance by a small number of system manufacturers, high entry barriers, and long verification cycles". On the one hand, accumulating clinical evidence and new product approvals are improving hospital acceptance; on the other hand, complex procedures, construction and operational difficulties still limit rapid popularization. Manufacturers that can simultaneously deliver robust treatment efficacy, efficiency and replicable deployment will have greater opportunities in the future.

Key Questions Addressed in this Report

What is the 10-year outlook for the global MR-Linac market?

What factors are driving MR-Linac market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do MR-Linac market opportunities vary by end market size?

How does MR-Linac break out by Type, by Application?

This report presents a comprehensive overview of the global MR-Linac market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • High-field MR-Linac
  • Low-field MR-Linac

Segment by Application

  • Prostate cancer
  • Pancreatic cancer
  • Liver cancer
  • Lung cancer
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global MR-Linac market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Prostate cancer, Pancreatic cancer, Liver cancer evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global MR-Linac Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$697
2025
Forecast
$1411
2032
CAGR
10.6%
2025–2032
Regions
5
global
Key companies
Elekta ABViewRay Systems, Inc.MagnetTx Oncology Solutions Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
High-field MR-LinacLow-field MR-Linac
By Application
Prostate cancerPancreatic cancerLiver cancerLung cancerOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 High-field MR-Linac
  • 3.1.3 Low-field MR-Linac
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Prostate cancer
  • 4.1.3 Pancreatic cancer
  • 4.1.4 Liver cancer
  • 4.1.5 Lung cancer
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Elekta AB
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 ViewRay Systems, Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 MagnetTx Oncology Solutions Ltd.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global MR-Linac market?
The global MR-Linac market is estimated at US$ 697 million in 2025 (base year) and is projected to reach US$ 1.33 billion by 2032.
What is the forecast CAGR for the MR-Linac market?
The market is expected to grow at a CAGR of 10.6% from 2026 to 2032, expanding from US$ 697 million in 2025 to US$ 1.33 billion in 2032, roughly 1.9 times its base-year value.
What is MR-Linac?
Magnetic resonance-guided radiation therapy system is a high-end tumor treatment equipment that deeply integrates magnetic resonance imaging (MR/MRI) with external beam radiation therapy devices, typically medical electronic linear accelerators, in both hardware and software.It aims to continuously acquire MR images with high soft-tissue contrast resolution before, during and even throughout treatment, and achieve more accurate dose delivery to tumors while better protecting surrounding normal tissues through online plan adaptation, real-time tracking and gating.In 2025, the global sales volume of MR-Linac was approximately 95 units, with an average price of about 7.5 million US dollars per.
What are the main segments of the MR-Linac market by type?
By type, the market is segmented into High-field MR-Linac and Low-field MR-Linac.
Which applications drive demand in the MR-Linac market?
Key applications covered include Prostate cancer, Pancreatic cancer, Liver cancer, Lung cancer and Others.
Who are the key players in the MR-Linac market?
Key players profiled include Elekta AB, ViewRay Systems and MagnetTx Oncology Solutions Ltd..
Which regions and countries are covered for MR-Linac?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the MR-Linac market?
What factors are driving MR-Linac market growth, globally and by region?
What challenges does the MR-Linac market face?
The current landscape is characterized by "dominance by a small number of system manufacturers, high entry barriers, and long verification cycles".
Who should buy the MR-Linac market report?
The report is intended for manufacturers and solution providers, distributors and end users in Prostate cancer, Pancreatic cancer and Liver cancer, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the MR-Linac market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.